Rituximab for the treatment of

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma

Boland A, Bagust A, Hockenhull J, Davis H, Chu P, Dickson R

Record ID 32007000907

English

Details

Project Status: Completed

Year Published: 2009

URL for published report: http://www.journalslibrary.nihr.ac.uk/hta/hta13Suppl2-06/#/abstract

URL for additional information: http://www.journalslibrary.nihr.ac.uk/hta/volume-13/suppl-2-article-6

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

MeSH Terms

Cost-Benefit Analysis
Drug Costs
Drug Resistance, Neoplasm
Neoplasm Staging
Patient Compliance
Randomized Controlled Trials as Topic
Survival Analysis
Technology Assessment, Biomedical
Treatment Outcome
Antibodies, Monoclonal
Antineoplastic Agents
Lymphoma, Follicular
Neoplasm Recurrence, Local
Research

Contact

Organisation Name: NIHR Health Technology Assessment programme

Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK

Contact Name: journals.library@nihr.ac.uk

Contact Email: journals.library@nihr.ac.uk

This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.